Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Common Equity (2016 - 2025)

Healthy Extracts' Common Equity history spans 11 years, with the latest figure at $24.0 million for Q4 2025.

  • For Q4 2025, Common Equity rose 5755.49% year-over-year to $24.0 million; the TTM value through Dec 2025 reached $24.0 million, up 5755.49%, while the annual FY2025 figure was $24.0 million, 5755.49% up from the prior year.
  • Common Equity reached $24.0 million in Q4 2025 per HYEX's latest filing, roughly flat from $24.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $24.1 million in Q3 2025 to a low of $60508.0 in Q1 2025.
  • Average Common Equity over 5 years is $3.5 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Common Equity: crashed 88.47% in 2024, then soared 5755.49% in 2025.
  • A 5-year view of Common Equity shows it stood at $2.5 million in 2021, then fell by 24.25% to $1.9 million in 2022, then crashed by 48.99% to $954590.0 in 2023, then crashed by 57.01% to $410377.0 in 2024, then skyrocketed by 5755.49% to $24.0 million in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Common Equity are $24.0 million (Q4 2025), $24.1 million (Q3 2025), and $477958.0 (Q2 2025).